Blog
15 Articles
![Slide of pancreatic cancer](https://letswinpc.org/wp-content/uploads/2023/08/Adenocarcinoma_of_Pancreas_FNA.jpg)
Targeting Pancreatic Cancer Cell Growth
Researchers are testing a new drug targeting cell growth in solid tumors, including pancreatic cancer.
![Pishvaian](https://letswinpc.org/wp-content/uploads/2023/07/Pishvaian-horiz2.jpg)
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
![neon lights in the shape of DNA](https://letswinpc.org/wp-content/uploads/2023/06/neon-DNA.jpg)
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
![Kenneth Yu, MD](https://letswinpc.org/wp-content/uploads/2021/02/Ken-Yu-v2.jpg)
Blood-Based Test Predicts What Drugs May Work Best
Dr. Kenneth Yu is testing a blood-based assay that looks at which types of chemotherapies will work best for each pancreatic cancer patient.
![Fractal flame ribbons in whte and red on a black background](https://letswinpc.org/wp-content/uploads/2022/09/ct2020may15.jpg)
Targeted Therapy to Inhibit Connective Tissue Growth in Pancreatic Cancer
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
![DNA aqua pipette](https://letswinpc.org/wp-content/uploads/2022/10/DNA-aqua-pipette.jpg)
Exploiting DNA Mutations For Pancreatic Cancer Treatment
Dr. James Cleary explains how the researchers at Dana-Farber are looking to make PARP inhibitors even more effective for pancreatic cancer patients.
![Dr. Allyson Ocean](https://letswinpc.org/wp-content/uploads/2022/10/Allyson_Ocean.jpg)
Pancreatic Cancer: 2018 Highlights And Looking Forward to 2019
Dr. Allyson Ocean leads an overview of the new treatments and protocol from 2018 as well as what are the next steps in treatment for 2019.
![Draining board](https://letswinpc.org/wp-content/uploads/2022/10/Draining-board.jpg)
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
![Dr. Margaret Tempero](https://letswinpc.org/wp-content/uploads/2022/10/Tempero2015-Newsletter.jpg)
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
![Cancer Moonshot meeting with Vice President Joe Biden and President Barack Obama](https://letswinpc.org/wp-content/uploads/2022/10/020116_VPMoonshotMeeting-e1482801087994.jpg)
The Cancer Moonshot
Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.